Olanzapine
Olanzapine
- Category
- pharmaceutical · Atypical antipsychotic
- Record
- specific compound · in current use
- Identifiers
- CAS 132539-06-1
- Aliases
- —
Atypical antipsychotic. Metabolic disruption at therapeutic doses is recorded separately from dopamine pharmacology and from mitochondrial hypotheses.
Flags: pharmaceutical
Phase-1 numbers are seed hypotheses. They are not curated consensus, not a toxicity total, and not a statement of human risk. Association is not written as causation.
| Context | Life stage | Type | Dose metric | Real-world relevance |
|---|---|---|---|---|
Adults prescribed olanzapine Therapeutic dose, not overdose. | adult | therapeutic | prescribed dose | high |